Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.64B
Enterprise Value4.72B
P/E Ratio70.3
PEG Ratio3.1
Price/Sales Ratio2.16
Price/Book Ratio2.3
Enterprise/Revenue2.58
Enterprise/EBITDA27.32

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue1.76B
Revenue/Share3.13
Gross Profit492.23M
EBITDA199.48M
Net Income60M
Diluted EPS0.11

Balance Sheet

Total Cash214.32M
Total Cash/Share0.39
Total Debt946.2M
Total Debt/Equity0.59
Current Ratio1.26
Book Value Per Share3.02

Price History

52-Week Change0.45
52-Week High9.44
52-Week Low6.24
Moving Average 50 Days7.89
Moving Average 200 Days7.42

Statistics

Average Volume18.2M
Shares Outstanding559.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.01
Trailing Annual Dividend Yield0.21
Payout Ratio0.89
Last Split Factor13:10
Last Split DateMay 12, 2010
AD